Zurück
  • Poster
  • P 118

Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Antiviral therapy and resistance

Session

Antiviral therapy and resistance

Thema

  • Antiviral therapy and resistance

Mitwirkende

Stefanie Rauch (Innsbruck / AT), Helge Schöppe (Innsbruck / AT), David Bante (Innsbruck / AT), Francesco Costacurta (Innsbruck / AT), Seyed Arad Moghadasi (Minneapolis, MN / US), Dr. Laura Krismer (Innsbruck / AT), Anna Sauerwein (Innsbruck / AT), Anne Heberle (Innsbruck / AT), Toni Rabensteiner (Innsbruck / AT), Teresa Kaserer (Innsbruck / AT), Professor Dorothee von Laer (Innsbruck / AT), Dr. Emmanuel Heilmann (Innsbruck / AT)

    • v1.19.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Impressum
    • Datenschutz